Stem Cell Treatment For Stroke - ReNeuron Announces Interim Results
5th Dec 2005, 09:12 GMT
ReNeuron announced interim results and stated it is on track to enter clinical trials in 2006 for its stem cell treatment for stroke, which could make ReNeuron the first company in the world to have a stem cell drug in human trials for a major indication (stroke). ReNeuron Group plc Interim Results for the six months ended September 30, 2005 - - Lead ReN001 stroke therapy progresses to plan, including positive pre-IND meeting with FDA- - Initial results of late pre-clinical studies show that ReN001 stem cells are non-tumour forming- - Manufacturing scale-up of ReN001 on track for completion to full GMP standards- - ReNcell hepatocyte (liver) cell line developed for drug discovery applications, generating significant interest from the pharmaceutical industry- - Landmark cross-licence signed with StemCells, Inc... click link for more info.
Stem Cell Treatment For Stroke - ReNeuron Announces Interim Results related news:
- Stem Cell Ventures, Inc. Announces Acquisition of Stem Cell Ventures Limited — ArriveNet : Business
- FDA OKs testing drug for Crohn's — baltimoresun.com - business
- Stressed-out stem cell pioneer hospitalized — MSNBC.com: Technology & Science
- Protherics Announces Interim Results For The 6 Months Ended 30 September 2005 — StratWire - Business of Healthcare NewsFeed
- Rights to stem cell discoveries may be retained by scientists — SignOnSanDiego.com: State
- Tiny Bubbles singer receives stem cell implant for heart — Medical Informatics Insider
- Team welsomes stem cell boost — CEN : City News
- Hospital in stem cell therapy breakthrough — Wood and Vale
- Stem Cell Therapeutics Corp. und Medicon A/S schliessen Verabreichung von Ntx(TM)-265 an Patienten in der Phase-I-Studie ab — Presseportal
- Protherics Plc Announces Interim Results For The Six Months Ended 30 September 2005 — ArriveNet : Health
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes